Pregnancy complications in polycystic ovary syndrome patients

Gynecological Endocrinology

Volumn 31, Issue 2, 2015, Pages 87-91

  Katulski, Krzysztof ^a   Czyzyk, Adam ^a   Podfigurna Stopa, Agnieszka ^a   Genazzani, Andrea R ^b   Meczekalski, Blazej ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Gestational diabetes; Gestational hypertension; Insulin resistance; PCOS; Pregnancy

Indexed keywords

ARTERIAL STIFFNESS; ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH BIRTH WEIGHT; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LARGE FOR GESTATIONAL AGE; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; OBESITY; OVARY POLYCYSTIC DISEASE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; COMPLICATION; DIABETES, GESTATIONAL; FETAL MACROSOMIA; HYPERTENSION, PREGNANCY-INDUCED; NEWBORN; POLYCYSTIC OVARY SYNDROME; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS;

DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; POLYCYSTIC OVARY SYNDROME; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84921326063     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.974535     Document Type: Article

References (44)

1. Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRFJASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97:28-38.
2. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Oxford: Blackwell; 2002:59-69.
3. Katulski K, Bornstein S, Figiel M. Typical hormonal profile s are accompanied by increased immunoreactivity of theca folliculi steroid 17 alpha hydroxylase P450 in polycystic ovary syndrome. J Endocrinol Invest 1998;21:304-9.
4. Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010;95: 2038-49.
5. Boivin J. A review of psychosocial interventions in infertility. Soc Sci Med 2003;57:2325-41.
6. Katulski K, Meczekalski B. Objective assessment of hyperandrogenism and modern ideas on PCOS treatment. Arch Perinat Med 2011;17:210-16.
7. Kamalanathan S, Sahoo JP, Sathyapalan T. Pregnancy in polycystic ovary syndrome. Indian J Endocrinol Metab 2013;17: 37-43.
8. Weghofer A, Munne S, Chen S, et al. Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril 2007;88:900-5.
9. Lindenberg S. New approach in patients with polycystic ovaries, lessons for everyone. Fertil Steril 2013;99:1170-2.
10. Rice S, Christoforidis N, Gadd C, et al. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from an ovulatory women with polycystic ovaries. Hum Reprod 2005;20:373-81.
11. Wood JR, Dumesic DA, Abbott DH, et al. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 2007;92:705-13.
12. Harris SE, Maruthini D, Tang T, et al. Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndrome. Hum Reprod 2010;25:2305-15.
13. Katulski K, Meczekalski B, Ghrelin and fertility. Prz. Menopauz 2012;11:26-30.
14. Hickey TE, Legro RS, Norman RJ. Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:2789-91.
15. Bruyneel A, Catteau-Jonard S, Decanter C, et al. Polycystic ovary syndrome: what are the obstetrical risks? Gynecol Obstet Fertil 2014;42:104-11.
16. Hu S, Leonard A, Seifalian A, Hardiman P. Vascular dysfunction during pregnancy in women with polycystic ovary syndrome. Hum Reprod 2007;22:1532-9.
17. Sir-Petermann T, Ladrón de Guevara A, Villarroel AC, et al. Polycystic ovary syndrome and pregnancy. Rev Med Chil 2012;140: 919-25.
18. ACOG. Committee on Practice Bulletins-Obstetrics. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2011; 98:159-67.
19. de Vries MI, Dekker GA, Schoemaker J. Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study. Eur J Obstet Gynecol Reprod Biol 2008;76:91-5.
20. Kashyap S, Claman P. Polycystic ovary disease and the risk of pregnancy-induced hypertension. J Reprod Med 2009;45: 991-4.
21. Qin JZ, Pang LH, Li MJ, et al. Obstetric complications in women with polycystic ovary syndrome: a systematic review and metaanalysis. Reprod Biol Endocrinol 2013;11:56.
22. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 2009;353:1789-92.
23. Shayeb AG, Harrild K, Bhattacharya S. Birth weight and ovulatory dysfunction. BJOG 2014;121:281-9.
24. Ibanez L, Potau N, Francois L, de Zegher F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 2008;83: 3558-62.
25. Benitez R, Sir-Petermann T, Palomino A, et al. Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome. Rev Med Chil 2011;129:707-12.
26. Laitinen J, Taponen S, Martikainen H, et al. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. lnt J Obes Relat Metab Disord 2003;27:710-15.
27. Palomba S, Falbo A, Russo T, et al. Uterine blood flow in pregnant patients with polycystic ovary syndrome: relationships with clinical outcomes. BJOG 2010;117:711-21.
28. Nahuis MJ, Oude Lohuis EJ, Bayram N, et al. Pregnancy complications and metabolic disease in women with clomiphene citrate-resistant anovulation randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotropins: a 10-year follow-up. Fertil Steril 2014;101:270-4.
29. Wax JR. Risks and management of obesity in pregnancy: current controversies. Curr Opin Obstet Gynecol 2009;21:117-23.
30. Galazis N, Docheva N, Nicolaides KH, Atiomo W. Proteomic biomarkers of preterm birth risk in women with polycystic ovary syndrome (PCOS): a systematic review and biomarker database integration. PLoS One 2013;8:53801.
31. Legro RS, Kunselman AR, Dodson WC. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 2009;84: 165-9.
32. Glueck CJ, Goldenberg N, Pranikoff J, et al. Effects of metformindiet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome. Curr Med Res Opin 2013;29:55-62.
33. Ryan EA. Hormones and insulin resistance during pregnancy. Lancet 2009;362:1777-8.
34. Nelson SM, Matthews P, Poston L. Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Hum Reprod 2010;16:255-75.
35. Boomsma CM, Eijkemans MI, Hughes EG, et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod 2006;12:673-8.
36. D'Anna R, Di Benedetto V, Rizzo P, et al. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecol Endocrinol 2012;28: 440-2.
37. Palomba S, Falbo A, Russo T, et al. The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome. Diabetes Care 2012;35:861-7.
38. Homburg R. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab 2006;20:281-92.
39. Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551-66.
40. Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab 2006; 20:235-44.
41. Boomsma CM, Fauser BC, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008;1:72-84.
42. Palomba S, Falbo A, Russo T, et al. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril 2010;94: 1805-11.
43. Carmina E. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Gynecol 2004;56:1-6.
44. Vanky E, Stridsklev S, Heimstad R, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 2010;95:E448-55.